State Street Global Advisors: Insufficient Reason to Extend Duration Amid Upward Yield Pressure
智通财经2026/10/08 06:16Strategists at State Street Global Advisors stated that the yield curve may not be as attractive as it appears on the surface. In a report, they remarked: "If we are indeed entering a market environment more similar to that of the 2000s, it is notable that the current yield curve does not seem particularly steep." They pointed out that if the market starts to price in a higher term premium, yields may face further upward pressure. In their view, the rise in government bond yields is one of the most significant developments in the fixed income market in recent years. They stated: "Nevertheless, although bond yields have become more attractive, we do not believe that the case for extending duration has become significantly more compelling."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot silver hits $59/ounce, down 1.29% intraday
Spot silver has just touched the $59.00/oz mark, currently quoted at $59.00/oz, down 1.29% on the day. The main COMEX silver futures contract is now trading at $59.28/oz, down 1.68% on the day.
ECB’s Cipollone says the purpose of the digital euro is not to replace cash
European Central Bank Executive Board member Cipollone stated that while some people may have initially worried that the purpose of the digital euro was to replace cash, this is not the case. More than 80% support a single currency. People trust the euro, our common currency.

Finland’s trade deficit in August reached 1.145 billion euros.
Finland recorded a trade deficit of 1.145 billions euros in August.

Google (GOOGL.US)-backed AI pharmaceutical company Isomorphic Labs starts a new round of fundraising: received $2.1 billions just five months ago, this round aims for a $50 billions valuation.
According to sources cited by Zhitong Finance APP, Isomorphic Labs, an AI drug development startup spun out from Google DeepMind, a subsidiary of Alphabet (GOOGL.US), is in preliminary talks for a new round of financing with a target valuation of at least $40 billion.
